Biaxin News
Advanced Life Sciences shares up 22% after cethromycin trial results - CNNMoney.com
In the trial, cethromycin had a statistical non-inferiority to the clinical cure rate to Biaxin, the current standard treatment for CAP. ...
Advanced Life Sciences Holdings Reports Effective Results From CL ... - RTT News
According to the results, cethromycin cured 94.0% of patients with CAP, compared to Biaxin, a current standard of care treatment for CAP, which cured 93.8% ...
Advanced Life Sciences cites study data - CNNMoney.com
In a previous Phase III clinical trial, the antibiotic met its goal of being as effective as Abbott Laboratories (NYSE:ABT) ' Biaxin. ...
Big Results For Promising Bug Killer - Forbes
Both Biaxin and Zithromax have seen their patent protection expire. Resistance to penicillin can be as high as 60%, the company said. ...
ADLS: Positive Ph III Trial for Oral Antibiotic vs Abbott's Biaxin ... - Trading Markets (press release)
The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Abbott's (ABT) Biaxin(R) (clarithromycin), a current standard of ...
Cethromycin Achieves All Endpoints in Second Pivotal Phase III ... - CNNMoney.com
The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Biaxin(R) (clarithromycin), a current standard of care treatment for ...
Advanced Life Sciences' pneumonia drug tests well against rival ... - Chicago Sun-Times
Both cethromycin and Biaxin are used to treat pneumonia contracted outside of a hospital. The new cethromycin would be the company's first product. ...
ADLS: Positive Ph III Trial for Oral Antibiotic vs Abbott's Biaxin ... - Trading Markets (press release)
The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Abbott's (ABT) Biaxin(R) (clarithromycin), a current standard of ...
JC Penney, Barclays Shed Value - Wall Street Journal
... or 25.8%, to 2.39 after the company said its pneumonia treatment, cethromycin, performed better than the standard Biaxin treatment in a Phase III trial. ...
ADLS: Positive Ph III Trial for Oral Antibiotic vs Abbott's Biaxin ... - Trading Markets (press release)
The study results showed that cethromycin cured 94.0% of patients with CAP, compared to Abbott's (ABT) Biaxin(R) (clarithromycin), a current standard of ...
Biaxin RSS Feed